blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2289911

EP2289911 - Therapeutic use of a growth factor, NsG33 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.02.2012
Database last updated on 24.04.2024
Most recent event   Tooltip24.02.2012Application deemed to be withdrawnpublished on 28.03.2012  [2012/13]
Applicant(s)For all designated states
NsGene A/S
Baltorpvej 154
2750 Ballerup / DK
[N/P]
Former [2011/09]For all designated states
NsGene A/S
Baltorpvej 154
2750 Bellerup / DK
Inventor(s)01 / Grønborg, Mette
Nebbegårdsbakken 51
2400 Copenhagen NV / DK
02 / Kusk, Philip
Baunesvinget 20
3450 Lynge / DK
03 / Blom, Nikolaj
Nebbegårdsbakken 51
2400 Copenhagen NV / DK
04 / Petersen, Thomas Nordahl
Hillerødgade 55, st.th.
2200 Copenhagen N / DK
05 / Johansen, Teit E.
Stampeengen 26
2970 Hørsholm / DK
06 / Brunak, Søren
Gammel Vartov Vej 22
2900 Hellerup / DK
07 / Wahlberg, Lars Ulrik
259 Riverside Dr.
Tiverton, RI 02878 / US
 [2011/09]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[N/P]
Former [2011/09]Høiberg A/S
St. Kongensgade 59 A
1264 Copenhagen K / DK
Application number, filing date10182987.730.03.2005
[2011/09]
Priority number, dateDK2004000051030.03.2004         Original published format: DK 200400510
US20040575086P28.05.2004         Original published format: US 575086 P
DK2004000084328.05.2004         Original published format: DK 200400843
[2011/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2289911
Date:02.03.2011
Language:EN
[2011/09]
Type: A3 Search report 
No.:EP2289911
Date:30.03.2011
[2011/13]
Search report(s)(Supplementary) European search report - dispatched on:EP02.03.2011
ClassificationIPC:C07K14/475, C12N15/12, A61K38/18, A61K31/7088, A61K31/713, A61P25/00, A61P37/00, A61L27/38, C12N15/86, A61K9/00, // A61K38/00
[2011/09]
CPC:
C07K14/475 (EP,US); A61K38/16 (KR); A01K67/027 (EP,US);
A61K38/185 (EP,US); A61P13/12 (EP); A61P21/00 (EP);
A61P21/02 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/04 (EP); A61P25/08 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P25/32 (EP); A61P25/36 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P27/16 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/02 (EP); A61P3/10 (EP);
A61P31/00 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P39/02 (EP);
A61P9/10 (EP); A01K2207/05 (EP,US); A01K2207/20 (EP,US);
A01K2227/105 (EP,US); A01K2267/0356 (EP,US); A61K38/00 (EP,US);
A61K38/17 (EP,US); C12N2799/027 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/09]
TitleGerman:Therapeutische Verwendung des Wachstumsfaktors nsg33[2011/09]
English:Therapeutic use of a growth factor, NsG33[2011/09]
French:Utilisation thérapeutique du facteur de croissance nsg33[2011/09]
Examination procedure30.09.2011Examination requested  [2011/45]
01.10.2011Application deemed to be withdrawn, date of legal effect  [2012/13]
14.11.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2012/13]
Parent application(s)   TooltipEP05717160.5  / EP1745069
EP09156744.6  / EP2075254
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050717160) is  21.03.2007
Fees paidRenewal fee
19.01.2011Renewal fee patent year 03
19.01.2011Renewal fee patent year 04
19.01.2011Renewal fee patent year 05
19.01.2011Renewal fee patent year 06
03.03.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0139786  (INNOGENETICS NV [BE], et al) [X] 1-15 * figure -; example -; claim - *;
 [X]WO0154474  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-15 * claim -; sequences 675,845,255,425 *;
 WO0155440  [ ] (HUMAN GENOME SCIENCES INC [US], et al) [ ] * paragraph [0638] - paragraph [0655]; claim -; sequences 675,845,255,425 *;
 [X]WO0157190  (HYSEQ INC [US], et al) [X] 1-15 * page 59 - page 61; example -; claim -; tables 2-6; sequences 1401,3369,417,2385 *;
 [X]WO0183510  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-15 * page 49 - page 51; claim -; sequences 31,93,94 * * page 213 - page 225 * * page 245 - page 253 *;
 [XP]WO2004035732  (FIVE PRIME THERAPEUTICS INC [US], et al) [XP] 1-15 * paragraph [0140] - paragraph [0147]; claim -; sequence 91 *;
    [ ] - "Human protein SEQ ID NO 1401.", Geneseq, (20011106), Database accession no. AAM78739, URL: EBI, XP002334619 [ ] * the whole document *
    [ ] - "Human protein SEQ ID NO 3369.", Geneseq, (20011106), Database accession no. AAM79723, URL: EBI, XP002334620 [ ] * the whole document *
    [ ] - "Human cDNA SEQ ID NO: 675.", Geneseq, (20020110), Database accession no. ABB10367, URL: EBI, XP002334621 [ ] * the whole document *
    [ ] - "Human cDNA SEQ ID NO: 845.", Geneseq, (20020110), Database accession no. ABB10537, URL: EBI, XP002334622 [ ] * the whole document *
    [ ] - "Human cDNA SEQ ID NO: 255.", Geneseq, (20020110), Database accession no. ABA06589, URL: EBI, XP002334623 [ ] * the whole document *
    [ ] - "Human cDNA SEQ ID NO: 425.", Geneseq, (20020110), Database accession no. ABA06759, URL: EBI, XP002334624 [ ] * the whole document *
    [ ] - "Human secreted protein encoding polypeptide SEQ ID NO 93.", Geneseq, (20020315), Database accession no. ABB57447, URL: EBI, XP002334625 [ ] * the whole document *
 [XDP]  - NISHINO JINSUKE ET AL, "Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, (20040505), vol. 23, no. 9, ISSN 0261-4189, pages 1998 - 2008, XP002334608 [XDP] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.emboj.7600202
    [ ] - "Human secreted protein SEQ ID #91.", Geneseq, (20040812), Database accession no. ADP29324, URL: EBI, XP002334626 [ ] * the whole document *
 [A]  - COLTON C K, "Engineering challenges in cell-encapsulation technology", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (19960501), vol. 14, no. 5, doi:10.1016/0167-7799(96)10021-4, ISSN 0167-7799, pages 158 - 162, XP004035786 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/0167-7799(96)10021-4
 [AD]  - NIELSEN H ET AL, "A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites", INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SINGAPORE, SG, (19971001), vol. 8, no. 5-6, ISSN 0129-0657, pages 581 - 599, XP009144608 [AD] 1-15 * the whole document *
 [A]  - HEIJNE VON G, "A NEW METHOD FOR PREDICTING SIGNAL SEQUENCE CLEAVAGE SITES", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, (19860101), vol. 14, no. 11, ISSN 0305-1048, pages 4683 - 4690, XP001189533 [A] 1-15 * the whole document *
 [A]  - "2023-57 Mouse E14.5 retina lambda ZAP II Library Mus musculus cDNA, mRNA sequence.", EMBL, (20011221), Database accession no. BG806341, URL: EBI, XP002334627 [A] 1-15 * the whole document *
 [A]  - MU X ET AL, "Gene expression in the developing mouse retina by EST sequencing and microarray analysis.", NUCLEIC ACIDS RESEARCH. 15 DEC 2001, (20011215), vol. 29, no. 24, ISSN 1362-4962, pages 4983 - 4993, XP002334609 [A] 1 * the whole document *

DOI:   http://dx.doi.org/10.1093/nar/29.24.4983
by applicantUS4352883
 US4353888
 US4407957
 US4657760
 US4762915
 US4868116
 US4883666
 US4892538
 US4968733
 US4976859
 US5000958
 US5082670
 US5084350
 US5106627
 US5156844
 US5158881
 WO9219195
 US5169637
 US5185154
 US5206344
 US5219990
 US5225212
 WO9322437
 US5283187
 US5284761
 WO9505452
 US5399346
 WO9516709
 WO9524929
 US5460959
 WO9530761
 US5487739
 WO9607399
 US5512600
 US5550050
 US5554148
 WO9640072
 WO9701357
 WO9703692
 US5618531
 US5639275
 US5654007
 US5654010
 US5653975
 US5653687
 WO9734586
 US5677158
 WO9744065
 WO9805304
 US5780014
 US5798113
 US5800828
 US5814607
 US5904144
 WO9952573
 EP0973872
 US6027721
 US6042579
 US6063757
 US6299895
 US6309634
 US6361771
 US2002037281
 EP1223966
 US6439427
 WO02078730
 WO03004527
 US2003031700
 US6555674
 US6683058
    - BECKER; BONNI, PROG NEUROBIOL., (200401), vol. 72, no. 1, pages 1 - 25
    - KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 2264 - 2268
    - KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 5873 - 5877
    - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410
    - TATIANA A. TATUSOVA; THOMAS L. MADDEN, "Blast 2 sequences - a new tool for comparing protein and nucleotide sequences", FEMS MICROBIOL. LETT., (1999), vol. 174, pages 247 - 250
    - PEARSON WR, METHODS MOL BIOL, (2000), vol. 132, pages 185 - 219
    - NISHINO ET AL., THE EMBO JOURNAL, (2004), vol. 23, pages 2998 - 2008
    - PETER DUCKERT; SOREN BRUNAK; NIKOLAJ BLOM, PROTEIN ENGINEERING, DESIGN AND SELECTION, (2004), vol. 17, pages 107 - 112
    - GREENE; TISCHLER, PROC. NATL. ACAD. SCI. U.S.A., (1976), vol. 73, page 2424
    - NIELSEN ET AL., MOL CELL NEUROSCI., (200404), vol. 25, no. 4, pages 629 - 41
    - VAUDRY ET AL., PROC NATL ACAD SCI U S A., (20020430), vol. 99, no. 9, pages 6398 - 403
    - BLOOM ET AL., ANN N Y ACAD SCI., (19981211), vol. 865, pages 274 - 89
    - CALDWELL ET AL., NATURE BIOTECHNOLOGY, (20010519), no. 5, pages 475 - 9
    - NAKAO ET AL., EXP NEUROL, (19960313), vol. 8, no. 1, pages 144 - 57
    - NAKAO ET AL., BRAIN RES DEV BARIN RES, (19951221), vol. 90, no. 1-2, pages 92 - 101
    - WIDMER ET AL., EUR J NEUROSCI, (19941101), vol. 6, no. 11, pages 1669 - 79
    - WOLD, F., Posttranslational Covalent Modification of Proteins, ACADEMIC PRESS, (1983), pages 1 - 12
    - SEIFTER ET AL., METH. ENZYMOL., (1990), vol. 182, pages 626 - 646
    - RATTAN ET AL., "Protein Synthesis: Posttranslational Modifications and Aging", ANN. N.Y. ACAD. SCI., (1992), vol. 663, pages 48 - 62
    - FEINBERG A P; VOGELSTEIN B, ANAL. BIOCHEM., (1983), vol. 132, pages 6 - 13
    - LASTBOM ET AL., TOXICOLOGY, (1998), vol. 125, pages 59 - 66
    - HOFFMANN ET AL., ALLERGY, (1999), vol. 54, pages 446 - 54
    - VOHR ET AL., ARCH. TOXOCOL., vol. 73, pages 501 - 9
    - KIMBER ET AL., J. TOXICOL. ENVIRON. HEALTH, vol. 53, pages 563 - 79
    - LENSCHOW ET AL., SCIENCE, (1992), vol. 257, pages 789 - 792
    - TURKA ET AL., PROC. NATL. ACAD. SCI USA, (1992), vol. 89, pages 11102 - 11105
    - Fundamental Immunology, RAVEN PRESS, (1989), pages 846 - 847
    - Fundamental Immunology, RAVEN PRESS, (1989), pages 840 - 856
    - Current Protocols in Immunology, PUB. GREENE PUBLISHING ASSOCIATES AND WILEY-INTERSCIENCE
    - HERRMANN ET AL., PROC. NATL. ACAD. SCI. USA, (1981), vol. 78, pages 2488 - 2492
    - HERRMANN ET AL., J. IMMUNOL., (1982), vol. 128, pages 1968 - 1974
    - HANDA ET AL., J. IMMUNOL., (1985), vol. 135, pages 1564 - 1572
    - TAKAI ET AL., IMMUNOL., (1986), vol. 137, pages 3494 - 3500
    - TAKAI ET AL., J. IMMUNOL., (1988), vol. 140, pages 508 - 512
    - BOWMAN ET AL., J. VIROLOGY, vol. 61, pages 1992 - 1998
    - BERTAGNOLLI ET AL., CELLULAR IMMUNOLOGY, (1991), vol. 133, pages 327 - 341
    - BROWN ET AL., J. IMMUNOL., (1994), vol. 153, pages 3079 - 3092
    - MALISZEWSKI, J. IMMUNOL., (1990), vol. 144, pages 3028 - 3033
    - "Assays for B cell function: In vitro antibody production", MOND, J. J.; BRUNSWICK, M., Current Protocols in Immunology, JOHN WILEY AND SONS, (1994), vol. 1, pages 3.8. 1 - 3.8,16
    - TAKAI ET AL., J. IMMUNOL., (1986), vol. 137, pages 3494 - 3500
    - BERTAGNOLLI ET AL., J. IMMUNOL., (1992), vol. 149, pages 3778 - 3783
    - GUERY ET AL., J. IMMUNOL., (1995), vol. 134, pages 536 - 544
    - INABA ET AL., JOURNAL OF EXPERIMENTAL MEDICINE, (1991), vol. 173, pages 549 - 559
    - MACATONIA ET AL., JOURNAL OF IMMUNOLOGY, (1995), vol. 154, pages 5071 - 5079
    - PORGADOR ET AL., JOURNAL OF EXPERIMENTAL MEDICINE, (1995), vol. 182, pages 255 - 260
    - NAIR ET AL., JOURNAL OF VIROLOGY, (1993), vol. 67, pages 4062 - 4069
    - HUANG ET AL., SCIENCE, (1994), vol. 264, pages 961 - 965
    - MACATONIA ET AL., JOURNAL OF EXPERIMENTAL MEDICINE, (1989), vol. 169, pages 1255 - 1264
    - BHARDWAJ ET AL., JOURNAL OF CLINICAL INVESTIGATION, (1994), vol. 94, pages 797 - 807
    - INABA ET AL., JOURNAL OF EXPERIMENTAL MEDICINE, (1990), vol. 172, pages 631 - 640
    - DARZYNKIEWICZ ET AL., CYTOMETRY, (1992), vol. 13, pages 795 - 808
    - GORCZYCA ET AL., LEUKEMIA, (1993), vol. 7, pages 659 - 670
    - GORCZYCA ET AL., CANCER RESEARCH, (1993), vol. 53, pages 1945 - 1951
    - ITOH ET AL., CELL, (1991), vol. 66, pages 233 - 243
    - ZACHARCHUK, JOURNAL OF IMMUNOLOGY, (1990), vol. 145, pages 4037 - 4045
    - ZAMAI ET AL., CYTOMETRY, (1993), vol. 14, pages 891 - 897
    - GORCZYCA ET AL., INTERNATIONAL JOURNAL OF ONCOLOGY, (1992), vol. 1, pages 639 - 648
    - ANTICA ET AL., BLOOD, (1994), vol. 84, pages 111 - 117
    - FINE ET AL., CELLULAR IMMUNOLOGY, (1994), vol. 155, pages 111 - 122
    - GALY ET AL., BLOOD, (1995), vol. 85, pages 2770 - 2778
    - TOKI ET AL., PROC. NAT. ACAD SCI. USA, (1991), vol. 88, pages 7548 - 7551
    - ANNALS OF PHARMACOTHERAPY, (1993), vol. 27, page 912
    - CANCER, (1993), vol. 41, page 1270
    - CANCER RESEARCH, (1984), vol. 44, page 1698
    - KOBAYASHI ET AL., MOL. CHEM. NEUROPATHOL., (1991), vol. 15, pages 193 - 206
    - TUSZYNSKI ET AL., GENE THERAPY, (1996), vol. 3, pages 305 - 314
    - LEHERICY ET AL., J. COMP. NEUROL., (1993), vol. 330, pages 15 - 31
    - Reminoton's Pharmaceutical Sciences, MAACK PUBLISHING CO.
    - JOHNSON ET AL., NAT. MED., (1996), vol. 2, pages 795 - 799
    - YASUDA, BIOMED. THER., (1993), vol. 27, pages 1221 - 1223
    - HORA ET AL., BIO/TECHNOLOGY, (1990), vol. 8, pages 755 - 758
    - "Design and Production of Single Immunization Vaccines Using Polylactide Polyglycolide Microsphere Systems", CLELAND, Vaccine Design: The Subunit and Adjuvant Approach, PLENUM PRESS, (1995), pages 439 - 462
    - "Controlled release of bioactive agents from lactide/glycolide polymer", LEWIS, Biodegradable Polymers as Drug Delivery Systems, MARCEL DEKKER, (1990), pages 1 - 41
    - FRALEY ET AL., TRENDS BIOCHEM. SCI., (1981), vol. 6, page 77
    - MANNINO ET AL., BIOTECHNIQUES, (1988), vol. 6, page 682
    - BILANG-BLEUEL ET AL., PROC. ACAD. NATI. SCI. USA, (1997), vol. 94, pages 8818 - 8823
    - CHOI-LUNDBERG ET AL., EXP. NEUROL., (1998), vol. 154, pages 261 - 275
    - CHOI-LUNDBERG ET AL., SCIENCE, (1997), vol. 275, pages 838 - 841
    - MANDEL ET AL., PROC. ACAD. NATL. SCI. USA, (1997), vol. 94, pages 14083 - 14088
    - MESSING ET AL., NUCLEIC ACIDS RES., (1981), vol. 9, page 309
    - MAXAM ET AL., METHODS IN ENZYMOLOGY, (1980), vol. 65, page 499
    - MANIATIS ET AL., MOLECULAR CLONING, (1982), pages 133 - 134
    - BANERJI ET AL., CELL, (1981), vol. 27, page 299
    - SCIENCE, (1980), vol. 209, page 1406
    - BREATHNACH; CHAMBON, ANN. REV. BIOCHEM., (1981), vol. 50, page 349
    - JOLLY ET AL., NUCLEIC ACIDS RES., (1983), vol. 11, page 1855
    - CAPECCHI ET AL., Enhancer and eukaryotic gene expression, COLD SPRING HARBOR LABORATORIES, (1991), pages 101 - 102
    - SCHMIDT ET AL., NATURE, (1985), vol. 314, page 285
    - ROSSI; DECROMBRUGGHE, PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 5590 - 5594
    - PROCKOP; KIVIRIKKO, N. ENG. J. MED., (1984), vol. 311, page 376
    - SMITH; NILES, BIOCHEM., (1980), vol. 19, page 1820
    - DE WET ET AL., J. BIOL. CHEM., (1983), vol. 258, page 14385
    - CHUA ET AL., CONNECTIVE TISSUE RES., (1990), vol. 25, pages 161 - 170
    - ELIAS ET AL., ANNALS N. Y. ACAD. SCI., (1990), vol. 580, pages 233 - 244
    - SELIGER ET AL., J. IMMUNOL., (1988), vol. 141, pages 2138 - 2144
    - SELIGER ET AL., J. VIROLOGY, (1988), vol. 62, pages 619 - 621
    - DAEWOONG ET AL., NATURE BIOTECHNOLOGY, vol. 19, pages 929 - 933
    - PIUCK, INT J EXP PATH, vol. 77, pages 269 - 278
    - LYSAGHT ET AL., J. CELL BIOCHEM., (1996), vol. 56, page 196
    - COLTON, TRENDS BIOTECHNOL., (1996), vol. 14, page 158
    - Biotech Source 87-88, FISHER SCIENTIFIC CO., (1987), pages 72 - 75
    - Sigma Cell Culture Catalog, SIGMA CHEMICAL CO., (1991), pages 162 - 163
    - LI; TURNER, EXP. EYE RES., (1988), vol. 47, pages 911 - 917
    - LOPEZ ET AL., INVEST. OPHTHALMOL. VIS. SCI., (1989), vol. 30, pages 586 - 588
    - PRICE TN; BURKE JF; MAYNE LV., "A novel human astrocyte cell line (A735) with astrocyte-specific neurotransmitter function", IN VITRO CELL DEV BIOL ANIM., (199905), vol. 35, no. 5, pages 279 - 88
    - DECKWERTH; JOHNSON, J. CELL BIOL., (1993), vol. 123, pages 1207 - 1222
    - PETER DUCKERT; SOREN BRUNAK; NIKOLAJ BLOM., PROTEIN ENGINEERING, DESIGN AND SELECTION, (2004), vol. 17, pages 107 - 112
    - HENRIK NIELSEN; JACOB ENGELBRECHT; SOREN BRUNAK; GUNNAR VON HEIJNE, PROTEIN ENGINEERING, (1997), vol. 10, pages 1 - 6
    - L. JUHL JENSEN; R. GUPTA; N. BLOM; D. DEVOS; J. TAMAMES; C. KESMIR; H. NIELSEN; H. H. STæRFELDT; K. RAPACKI; C. WORKMAN, J. MOL. BIOL., (2002), vol. 319, pages 1257 - 1265
    - L.J. JENSEN; R. GUPTA; H.H. STæRFELDT; S. BRUNAK, BIOINFORMATICS, (2003), vol. 19, pages 635 - 642
    - MYERS, E.W.; MILLER,W., COMPUT. APPL. BIOSCI., (1998), vol. 4, pages 11 - 17
    - KNUDSEN S; WORKMAN C; SICHERITZ-PONTEN T; FRIIS C., "GenePublisher: Automated analysis of DNA microarray data.", NUCLEIC ACIDS RES., (2003), vol. 31, no. 13, pages 3471 - 6
    - LENNON; AUFFRAY; POLYMEROPOULOS; SOARES, "An integrated molecular analysis of genomes and their expression", GENOMICS, (1996), vol. 33, pages 151 - 152
    - Current Protocols in Molecular Biology, WILLEY
    - DANIELS; BROWN, J. BIOL. CHEM., (2001), vol. 276, pages 22446 - 22452
    - NOMURA ET AL., DEV. NEUROSCI., (2001), vol. 23, pages 145 - 152
    - CISTERNI ET AL., J. NEUROCHEM., vol. 74, pages 1820 - 1828
    - FRIEDMAN; MYTILINEOU, NEUROSCI. LETT., (1987), vol. 79, pages 65 - 72
    - KARLSSON ET AL., BRAIN RES., (20021115), vol. 955, no. 1-2, pages 268 - 80
    - HEIKKILA ET AL., EURO J. PHARMACOL., (1984), vol. 103, pages 241 - 48
    - ZUFFEREY ET AL., J. VIROL, (1997), vol. 73, pages 2886 - 2892
    - ROSENBLAD ET AL., "In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin", MOL CELL NEUROSCI., (200002), vol. 15, no. 2, pages 199 - 214
    - VON SCHWEDLER ET AL., "Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells", VIROL., (199308), vol. 67, no. 8, pages 4945 - 55
    - SAUER; OERTEL, NEUROSCIENCE, (1994), vol. 59, pages 401 - 415
    - VILLA ET AL., EXP NEUROL, (2000), vol. 161, no. 1, pages 67 - 84
    - VILLA ET AL., EXP CELL RES., (20040401), vol. 294, no. 2, pages 559 - 70
    - NAKAO ET AL., EXP. NEUROL., (1996), vol. 138, pages 144 - 157
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.